JournalJournal of Physiology
PublisherBlackwell Publishing Ltd
MetadataShow full item record
AbstractSubcellular calcium signalling silencing is a novel and distinct cellular and molecular adaptive response to rapid cardiac activation. Calcium signalling silencing develops during short‐term sustained rapid atrial activation as seen clinically during paroxysmal atrial fibrillation (AF). It is the first ‘anti‐arrhythmic’ adaptive response in the setting of AF and appears to counteract the maladaptive changes that lead to intracellular Ca2+ signalling instability and Ca2+‐based arrhythmogenicity. Calcium signalling silencing results in a failed propagation of the [Ca2+]i signal to the myocyte centre both in patients with AF and in a rabbit model. This adaptive mechanism leads to a substantial reduction in the expression levels of calcium release channels (ryanodine receptors, RyR2) in the sarcoplasmic reticulum, and the frequency of Ca2+ sparks and arrhythmogenic Ca2+ waves remains low. Less Ca2+ release per [Ca2+]i transient, increased fast Ca2+ buffering strength, shortened action potentials and reduced L‐type Ca2+ current contribute to a substantial reduction of intracellular [Na+]. These features of Ca2+ signalling silencing are distinct and in contrast to the changes attributed to Ca2+‐based arrhythmogenicity. Some features of Ca2+ signalling silencing prevail in human AF suggesting that the Ca2+ signalling ‘phenotype’ in AF is a sum of Ca2+ stabilizing (Ca2+ signalling silencing) and Ca2+ destabilizing (arrhythmogenic unstable Ca2+ signalling) factors. Calcium signalling silencing is a part of the mechanisms that contribute to the natural progression of AF and may limit the role of Ca2+‐based arrhythmogenicity after the onset of AF. Copyright 2017 The Authors. The Journal of Physiology Copyright 2017 The Physiological Society
SponsorsThis work was supported by a Scientist Development Grant from the American Heart Association (14SDG20110054) to the author.
Identifier to cite or link to this itemhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85018911682&doi=10.1113%2fJP273045&partnerID=40&md5=f2701b44d440f15a82e4318760a6a364; http://hdl.handle.net/10713/10050
- Loss of microRNA-106b-25 cluster promotes atrial fibrillation by enhancing ryanodine receptor type-2 expression and calcium release.
- Authors: Chiang DY, Kongchan N, Beavers DL, Alsina KM, Voigt N, Neilson JR, Jakob H, Martin JF, Dobrev D, Wehrens XH, Li N
- Issue date: 2014 Dec
- Ryanodine receptor-mediated calcium leak drives progressive development of an atrial fibrillation substrate in a transgenic mouse model.
- Authors: Li N, Chiang DY, Wang S, Wang Q, Sun L, Voigt N, Respress JL, Ather S, Skapura DG, Jordan VK, Horrigan FT, Schmitz W, Müller FU, Valderrabano M, Nattel S, Dobrev D, Wehrens XHT
- Issue date: 2014 Mar 25
- Tachycardia-induced silencing of subcellular Ca2+ signaling in atrial myocytes.
- Authors: Greiser M, Kerfant BG, Williams GS, Voigt N, Harks E, Dibb KM, Giese A, Meszaros J, Verheule S, Ravens U, Allessie MA, Gammie JS, van der Velden J, Lederer WJ, Dobrev D, Schotten U
- Issue date: 2014 Nov
- Enhanced sarcoplasmic reticulum Ca2+ leak and increased Na+-Ca2+ exchanger function underlie delayed afterdepolarizations in patients with chronic atrial fibrillation.
- Authors: Voigt N, Li N, Wang Q, Wang W, Trafford AW, Abu-Taha I, Sun Q, Wieland T, Ravens U, Nattel S, Wehrens XH, Dobrev D
- Issue date: 2012 May 1
- Ultrastructural and functional remodeling of the coupling between Ca2+ influx and sarcoplasmic reticulum Ca2+ release in right atrial myocytes from experimental persistent atrial fibrillation.
- Authors: Lenaerts I, Bito V, Heinzel FR, Driesen RB, Holemans P, D'hooge J, Heidbüchel H, Sipido KR, Willems R
- Issue date: 2009 Oct 23